GSTA4
Basic information
Region (hg38): 6:52977948-52995304
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GSTA4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 11 | 11 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 11 | 0 | 1 |
Variants in GSTA4
This is a list of pathogenic ClinVar variants found in the GSTA4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-52978512-A-C | not specified | Uncertain significance (May 08, 2024) | ||
6-52978550-A-C | not specified | Uncertain significance (Dec 08, 2023) | ||
6-52978570-T-C | not specified | Uncertain significance (Feb 16, 2023) | ||
6-52982678-G-C | not specified | Uncertain significance (Mar 30, 2024) | ||
6-52982687-G-T | not specified | Uncertain significance (Dec 19, 2023) | ||
6-52984479-A-C | not specified | Uncertain significance (Apr 01, 2024) | ||
6-52984497-C-A | not specified | Uncertain significance (Dec 17, 2023) | ||
6-52984544-A-G | Benign (Dec 03, 2018) | |||
6-52984555-A-G | not specified | Uncertain significance (Feb 07, 2023) | ||
6-52984592-C-T | not specified | Uncertain significance (May 13, 2022) | ||
6-52985542-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
6-52985543-A-C | not specified | Uncertain significance (Jan 09, 2024) | ||
6-52987360-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
6-52987378-G-C | not specified | Uncertain significance (Nov 21, 2023) | ||
6-52994200-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
6-52994220-G-C | not specified | Uncertain significance (Jan 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GSTA4 | protein_coding | protein_coding | ENST00000370963 | 6 | 17426 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0110 | 0.952 | 125700 | 0 | 47 | 125747 | 0.000187 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.266 | 110 | 118 | 0.931 | 0.00000561 | 1466 |
Missense in Polyphen | 38 | 43.475 | 0.87406 | 569 | ||
Synonymous | -1.15 | 55 | 45.2 | 1.22 | 0.00000240 | 411 |
Loss of Function | 1.81 | 5 | 11.7 | 0.429 | 5.80e-7 | 136 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000245 | 0.000245 |
Ashkenazi Jewish | 0.00263 | 0.00258 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000621 | 0.0000615 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000242 | 0.000229 |
Other | 0.000340 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. This isozyme has a high catalytic efficiency with 4-hydroxyalkenals such as 4- hydroxynonenal (4-HNE). {ECO:0000269|PubMed:10329152, ECO:0000269|PubMed:20085333}.;
- Pathway
- Glutathione metabolism - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Fluid shear stress and atherosclerosis - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Nuclear Receptors Meta-Pathway;NRF2 pathway;Metapathway biotransformation Phase I and II;Glutathione conjugation;Phase II - Conjugation of compounds;glutathione-mediated detoxification;Biological oxidations;Metabolism;4-hydroxy-2-nonenal detoxification
(Consensus)
Recessive Scores
- pRec
- 0.209
Intolerance Scores
- loftool
- 0.736
- rvis_EVS
- -0.3
- rvis_percentile_EVS
- 32.62
Haploinsufficiency Scores
- pHI
- 0.155
- hipred
- N
- hipred_score
- 0.218
- ghis
- 0.573
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.861
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- glutathione metabolic process;xenobiotic metabolic process;glutathione derivative biosynthetic process
- Cellular component
- cytosol
- Molecular function
- glutathione transferase activity;protein binding;identical protein binding;protein homodimerization activity